GlassScriptPhysician profile
Etienne Sinquin
NPI 1962567065
$627.88
in general payments reported to CMS, 2019-2025
8 companies · $295 in 2025
The $295 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $17.79 · 2022: $39.97 · 2023: $128 · 2024: $147 · 2025: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $570.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $570.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $357.16 | 2023-2025 | Precision7, Rocklatan, Eysuvis |
| Bausch & Lomb Americas INC. | $73.64 | 2023-2024 | Infuse, Biotrue, Vyzulta |
| Abbvie INC. | $69.62 | 2022-2023 | Durysta |
| Rxsight INC | $41.47 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Johnson & Johnson Vision Care, INC. | $23.91 | 2024 | |
| Allergan, INC. | $23.15 | 2022 | |
| Dompe US, INC. | $21.14 | 2023 | Oxervate |
| Sun Pharmaceutical Industries INC. | $17.79 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Etienne Sinquin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.